Hirjak D, Northoff G, Thomann P A, Kubera K M, Wolf R C
Zentralinstitut für Seelische Gesundheit, Klinik für Psychiatrie und Psychotherapie, Medizinische Fakultät Mannheim, Universität Heidelberg, 68159, Mannheim, Deutschland.
Mind, Brain Imaging and Neuroethics Research Unit, The Royal's Institute of Mental Health Research, University of Ottawa, Ottawa, Kanada.
Nervenarzt. 2018 Jan;89(1):27-43. doi: 10.1007/s00115-017-0434-8.
Despite a growing body of evidence on motor dysfunction in schizophrenia spectrum disorders, the neuronal correlates of genuine motor abnormalities (GMA) are not fully elucidated at present. Moreover, the clinical relevance of a potential "motor intermediate phenotype" remains controversial. This systematic review aims at characterizing a "motor intermediate phenotype" in schizophrenia spectrum disorders. The second goal of this systematic review is to discuss GMA-associated brain alterations as potential biomarkers of psychosis risk syndrome and manifest motor symptoms against the background of current neuroimaging evidence. The detailed clinical assessment of GMA in the context of multimodal imaging could, in the future promote the early recognition of psychotic disorders and the initiation of disorder-oriented and individualized treatment. Taken as a whole the data provide initial evidence that motor dysfunction in schizophrenic spectrum disorders must be considered dimensionally. The predictive value of neurobiological results with respect to the transition to a life-threatening catatonia or the development of chronic dyskinesia, cannot currently be conclusively assessed.
尽管关于精神分裂症谱系障碍中运动功能障碍的证据越来越多,但目前真正的运动异常(GMA)的神经相关性尚未完全阐明。此外,潜在的“运动中间表型”的临床相关性仍存在争议。本系统评价旨在描述精神分裂症谱系障碍中的“运动中间表型”。本系统评价的第二个目标是在当前神经影像学证据的背景下,讨论与GMA相关的脑改变,作为精神病风险综合征和明显运动症状的潜在生物标志物。在多模态成像背景下对GMA进行详细的临床评估,未来可能会促进对精神障碍的早期识别以及启动针对疾病的个体化治疗。总体而言,数据提供了初步证据,表明精神分裂症谱系障碍中的运动功能障碍必须从维度上加以考虑。目前尚无法最终评估神经生物学结果对于转变为危及生命的紧张症或慢性运动障碍发展的预测价值。